Article info
PDFInterstitial lung disease
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
- Correspondence to Dr Amy Hajari Case; ashajari{at}gmail.com
Citation
Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
Publication history
- Received March 16, 2017
- Revised May 26, 2017
- First published June 28, 2017.
Online issue publication
January 19, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/